Answer
Dasatinib Zentiva treats adults with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic-phase chronic myelogenous leukaemia (CML); chronic-, accelerated- or blast-phase CML resistant or intolerant to prior therapy including imatinib; or Ph+ acute lymphoblastic leukaemia or lymphoid blast CML resistant or intolerant to prior therapy.
Sources for this answer
- Dasatinib 80mg film-coated tabletsZentiva · emc · SmPC §4.1 Therapeutic Indications · Version 12Document updated
Sources checked